Pharmaceutical Biology, Saarland University, Saarbrücken, Germany.
Respir Res. 2010 Sep 15;11(1):124. doi: 10.1186/1465-9921-11-124.
Investigations on pulmonary macrophages (MΦ) mostly focus on alveolar MΦ (AM) as a well-defined cell population. Characteristics of MΦ in the interstitium, referred to as lung interstitial MΦ (IM), are rather ill-defined. In this study we therefore aimed to elucidate differences between AM and IM obtained from human lung tissue.
Human AM and IM were isolated from human non-tumor lung tissue from patients undergoing lung resection. Cell morphology was visualized using either light, electron or confocal microscopy. Phagocytic activity was analyzed by flow cytometry as well as confocal microscopy. Surface marker expression was measured by flow cytometry. Toll-like receptor (TLR) expression patterns as well as cytokine expression upon TLR4 or TLR9 stimulation were assessed by real time RT-PCR and cytokine protein production was measured using a fluorescent bead-based immunoassay.
IM were found to be smaller and morphologically more heterogeneous than AM, whereas phagocytic activity was similar in both cell types. HLA-DR expression was markedly higher in IM compared to AM. Although analysis of TLR expression profiles revealed no differences between the two cell populations, AM and IM clearly varied in cell reaction upon activation. Both MΦ populations were markedly activated by LPS as well as DNA isolated from attenuated mycobacterial strains (M. bovis H37Ra and BCG). Whereas AM expressed higher amounts of inflammatory cytokines upon activation, IM were more efficient in producing immunoregulatory cytokines, such as IL10, IL1ra, and IL6.
AM appear to be more effective as a non-specific first line of defence against inhaled pathogens, whereas IM show a more pronounced regulatory function. These dissimilarities should be taken into consideration in future studies on the role of human lung MΦ in the inflammatory response.
对肺巨噬细胞(MΦ)的研究大多集中在肺泡 MΦ(AM)上,因为它是一种定义明确的细胞群体。而关于间质中的 MΦ,即肺间质 MΦ(IM),其特征则相当不明确。因此,在这项研究中,我们旨在阐明从人肺组织中分离得到的 AM 和 IM 之间的差异。
从接受肺切除术的患者的非肿瘤肺组织中分离出人 AM 和 IM。使用明场、电子或共聚焦显微镜观察细胞形态。通过流式细胞术和共聚焦显微镜分析吞噬活性。通过流式细胞术测量表面标志物表达。通过实时 RT-PCR 评估 Toll 样受体(TLR)表达模式以及 TLR4 或 TLR9 刺激后的细胞因子表达,并使用荧光珠免疫分析测定细胞因子蛋白的产生。
IM 比 AM 更小,形态上更具异质性,而吞噬活性在两种细胞类型中相似。与 AM 相比,IM 中 HLA-DR 的表达明显更高。尽管 TLR 表达谱分析显示两种细胞群之间没有差异,但 AM 和 IM 在激活后的细胞反应上明显不同。两种巨噬细胞群均被 LPS 以及减毒分枝杆菌株(牛分枝杆菌 H37Ra 和卡介苗)的 DNA 显著激活。虽然 AM 在激活后表达更高水平的促炎细胞因子,但 IM 在产生免疫调节细胞因子(如 IL10、IL1ra 和 IL6)方面更有效。
AM 似乎更有效地作为对抗吸入病原体的非特异性第一道防线,而 IM 则表现出更明显的调节功能。在未来关于人肺 MΦ 在炎症反应中的作用的研究中,应考虑到这些差异。